The main benefits of GLP-1 therapy include: Enhanced insulin secretion in response to meals Reduced glucagon release, preventing high blood sugar levels Slowed gastric emptying, leading to prolonged satiety Decreased appetite, which may help with weight loss Currently available GLP-1 receptor agonists include drugs like liraglutide (Victoza), semaglutide (Ozempic, Wegovy), exenatide (Byetta), and dulaglutide (Trulicity)
These are phase 2 figures from a single mid-stage trial and should be read as an early signal, not a settled result
All required injection supplies were included, plus extra sharps, alcohol wipes, and clear instructions covering injection technique, storage, and drug information
People who improve their eating habits and exercise regularly alongside medication may experience even better results
Drawing 10 units versus 12 units is a 20% dose difference, which is significant when you are trying to maintain a precise starting dose